Contralateral prophylactic mastectomy for breast cancer addressing peace of mind

JAMA

Volumn 310, Issue 8, 2013, Pages 793-794

  Katz, Steven J ^a   Morrow, Monica ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTRALATERAL PROPHYLACTIC MASTECTOMY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; HIGH RISK PATIENT; HUMAN; MASTECTOMY; MUTATIONAL ANALYSIS; PATIENT PREFERENCE; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; TREATMENT INDICATION; TUMOR SUPPRESSOR GENE;

EID: 84883092142     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.101055     Document Type: Short Survey

References (6)

1. Katz SJ, Morrow M. Addressing overtreatment in breast cancer: the doctor's dilemma [published online August 2, 2013]. Cancer. doi:10.1002/cncr. 28260.
2. Cemal Y, Albornoz CR, Disa JJ, et al. A paradigm shift in US breast reconstruction, II: the influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg. 2013;131(3):320e-326e.
3. Houssami N, Turner R, MorrowM. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257(2):249-255.
4. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362-1367.
5. Nichols HB, Berrington de González A, Lacey JV Jr, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29(12):1564-1569.
6. Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102(6):401-409.